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Mitophagy, a selective form of autophagy, is excessively activated in myocardial
ischemia/reperfusion (I/R). The study investigated whether aldehyde dehydrogenase 2
(ALDH2) exerted its cardioprotective effect by regulating mitophagy. Myocardial infarct
size and apoptosis after I/R in rats were ameliorated by Alda-1, an ALDH2 activator,
and aggravated by ALDH2 inhibition. Both in I/R rats and hypoxia/reoxygenation
H9C2 cells, ALDH2 activation suppressed phosphatase and tensin homolog-induced
putative kinase 1 (PINK1)/Parkin expression, regulating mitophagy, by preventing 4-
hydroxynonenal, reactive oxygen species and mitochondrial superoxide accumulation.
Furthermore, the effect was enhanced by ALDH2 inhibition. Thus, ALDH2 may protect
hearts against I/R injury by suppressing PINK1/Parkin–dependent mitophagy.
Keywords: ALDH2, Alda-1, myocardial ischemia/reperfusion, mitophagy, PINK1/Parkin, reactive oxygen species,
mitochondrial superoxide
INTRODUCTION
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is an allosteric tetrameric enzyme responsible
for the metabolism or detoxification of acetaldehyde and other toxic aldehydes, in particular 4-
hydroxynonenal (4HNE), as well as mitochondrial oxidative ATP generation and reactive oxygen
species (ROS) generation (Li et al., 2006; Ren, 2007; Li and Ren, 2008). ALDH2 activity can affect
the cellular response to oxidative stress both in vitro and in vivo (Li et al., 2004; Wenzel et al.,
2008). It can be affected by gene regulation, post-translational modifications and pharmacological
intervention (Chen et al., 2008; Choi et al., 2011; Lu et al., 2011). ALDH2 can be directly activated
by the activator Alda-1 and inhibited by the inhibitor Daidzin.
A recent study revealed an important role of ALDH2 in cardioprotection against ischemia
injury (Chen et al., 2008). ALDH2 has a dual regulatory paradox in cardioprotecting against
ischemia/reperfusion (I/R) injury via autophagy (Ma et al., 2011). Autophagy is triggered by energy
depletion, oxidative stresses, protein aggregates and damaged organelles (Tannous et al., 2008; Kim
et al., 2013). Despite many studies demonstrating the benefits of autophagy, excessive autophagy
can induce cell death in myocardial I/R injury (Matsui et al., 2007; Qiao et al., 2013).
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Mitophagy, a selective form of autophagy, is a specific process
for degradation of dysfunctional or damaged mitochondria to
maintain a healthy mitochondria population and mitochondrial
quality (Narendra et al., 2008; Poole et al., 2008). Starving,
hypoxemia, and ROS may trigger mitophagy, found associated
with several forms of neurodegeneration and cardiovascular
diseases (Youle and Narendra, 2011; Dorn and Kitsis, 2015).
Mitophagy can be regulated by the phosphatase and tensin
homolog-induced putative kinase 1 (PINK1)/Parkin pathway
(Springer and Kahle, 2011). Upon mitochondrial damage,
PINK1, a mitochondria-localized serine/threonine kinase,
globally accumulates on depolarized mitochondria and
recruits Parkin from the cytosol to mitochondria. Parkin,
an E3 ubiquitin ligase, catalyzes the polyubiquitination
of several substrates and triggers whole-mitochondrial
engulfment by autophagosomes and subsequent degradation
via the autophagosome lysosome pathway (Geisler et al.,
2010).
Nevertheless, the precise role of mitophagy in myocardial
I/R injury is unclear. Here, we explored the potential
involvement and function of mitophagy in the ALDH2-
elicited cardioprotective effect in myocardial I/R injury
in vivo and in vitro. We first confirmed that ALDH2 is
cardioprotective in myocardial I/R injury in rats, then
showed that ALDH2 inhibited excessive mitophagy and
increased the survival of I/R cardiomyocytes by reducing
4HNE and ROS levels. Finally, we investigated the potential
mechanism of ALDH2 in protecting against myocardial I/R
injury.
MATERIALS AND METHODS
Animals
All animal procedures were performed in accordance with the
guidelines of the Institute Animal User and Ethical Committees
at Shandong University were approved by it. Wistar rats were
purchased from Vital River Laboratory Animal Technology
Co. (Beijing) and were housed at a temperature-controlled
room under a 12:12 h light-dark circadian cycle. Six-to-eight-
week old adult male rats weighing 200–250 g were randomly
assigned to 4 groups (n = 12/group) for treatment:SHAM,
I/R, I/R plus Alda-1 (I/R + Alda-1), and I/R plus Daidzin
(I/R + Daidzin). Alda-1 and Daidzin were dissolved in DMSO.
Rats were administered 10 mg/kg Alda-1 (SML0462, Sigma,
USA) or 100 mg/Kg Daidzin (SML30408, Sigma, USA) through
intramyocardial injection into the left ventricular myocardium
5 min before 30 min ischemia followed by 120 min reperfusion.
Rats were anesthetized with pentobarbital sodium (100 mg/kg
body weight, intraperitoneal injection), intubated and ventilated
with oxygen (Rodent Ventilator, Harvard Apparatus, Millis, MA,
USA). The core temperature was maintained at 37◦C. For I/R
rats, we occluded the left anterior descending artery (LAD)
with an 8-0 nylon suture and polyethylene tubing to prevent
arterial injury for 30 min, followed by 120 min reperfusion
after left lateral thoracotomy. We used electrocardiography to
confirm ischemic repolarization changes (ST-segment elevation)
during coronary occlusion. Sham rats underwent the same
operation, except that the suture was placed around LAD but not
tied.
Histology
To measure myocardial infarction size, hearts were excised and
sectioned at 2 mm immediately. Then viable heart slices were
stained with 2,3,5-triphenyltetrazolium (TTC), which delineates
the infarct region. Images were taken with a Nikon camera
and analyzed by using Image-Pro Plus 6.0. To define apoptotic
levels of cardiac cells, hearts were extracted and fixed with 4%
formaldehyde for 24 h at 4◦C before embedding in paraffin for
sectioning. Heart tissue was sectioned at 4 µm and underwent
staining with an Apoptosis Assay Kit (Roche, Jinan, China).
Images were captured by using a microscope (Olympus, X41) and
were analyzed by using Image-Pro Plus 6.0.
Cell Culture
H9C2 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco, Grand Island, NY, USA)
supplemented with 10% (v/v) fetal bovine serum (FBS) and
1% penicillin/streptomycin. All cells were maintained in a
humidified incubator with 95% air/5% CO2 at 37◦C. For in vitro
study, H9C2 cells were incubated with the ALDH2 activator
Alda-1 (20 µM, Sigma, USA) or ALDH2 inhibitor Daidzin
(60 µM, Sigma, USA) for 30 min at 37◦C (95% air/5% CO2)
before a 120 min exposure to hypoxia (1% air/5% CO2/94%
N2), followed by 60 min reoxygenation (95% air/5% CO2).
Furthermore, H9C2 cells were treated with H/R in the absence
or presence of Alda-1 with the mitophagy inducer carbonyl
cyanide chlorophenylhydrazone (CCCP) (10 µM, Sigma, USA)
to evaluate whether and how ALDH2 could affect mitophagy in
cardiomyocytes.
Measurement of ALDH2 Activity
ALDH2 activity was measured in 33 mmol/L sodium pyropho-
sphate containing 0.8 mmol/L NAD+, 15 mmol/L propional-
dehyde, and 0.1 ml protein extract. Propionaldehyde, the
substrate of ALDH2, was oxidized in propionic acid, and NAD+
was reduced to NADH to estimate ALDH2 activity. NADH was
determined by spectrophotometric absorbance at 340 nm.
Measurement of Mitochondrial
Membrane Potential
H9C2 cells were incubated in the dark and mitochondrial
membrane potential was analyzed with an assay kit by
incubation with JC-1 (5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethyl-
imidacarbocyanine iodide, Beyotime, Nanjing, China) in serum-
free medium for 20 min at 37◦C. Then cells were washed
and imaged under a fluorescence microscope (Olympus,
X51). Normal mitochondria produce green fluorescence, and
depolarized or inactive mitochondria produce red fluorescence.
The ratio of red to green fluorescence was analyzed by use of
Image-Pro Plus 6.0 and used as an indicator of mitochondrial
membrane potential.
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Measurement of Cell Survival
Cell survival was assessed by WST-8 [2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetra-
zolium, monosodium salt] assays using Cell Counting Kit-8
(Solarbio, Beijing, China). H9C2 cells were incubated with 10 µl
WST-8 for 2 h at 37◦C. The optical density (OD) was measured
with a microplate reader (Bio-Rad, Berkeley, CA, USA) at
450 nm.
Measurement of Reactive Oxygen
Species (ROS)
H9C2 cells were incubated with 10 µM dichloro-dihydro-
fluorescein diacetate (DCFH-DA) with an ROS assay kit
(Beyotime, Nanjing, China) in serum-free medium at 37◦C for
30 min in the dark. Then cells were washed and observed under a
fluorescence microscope (Olympus, X51) and analyzed by using
Image-Pro Plus 6.0.
Measurement of MitoSOX Red
Mitochondrial Superoxide Indicator
H9C2 cells were incubated with 5 µM MitoSOX Red
Mitochondrial Superoxide Indicator (YESEN, Shanghai,
China) in serum-free medium at 37◦C for 10 min in the dark.
Then cells were washed and observed under a fluorescence
microscope (Olympus, X51) and analyzed by using Image-Pro
Plus 6.0.
Measurement of Mitophagy
The co-localization of mitochondria with mitophagy protein
markers was used for detection. H9C2 cells were stained with the
mitochondria marker COX IV and mitophagy markers PINK1
and Parkin. The cells were blocked with 5% goat serum and
incubated overnight at 4◦C with the primary antibody anti-
PINK1 (Abcam23707, Rabbit polyclonal to PINK1, Cambridge,
MA, USA, 1:100), anti-Parkin (Abcam15954, Rabbit polyclonal
to Parkin, Cambridge, MA, USA, 1:200), and anti-COX IV
(Abcam33985, Mouse monoclonal to COX IV, Cambridge, MA,
USA, 1:100), then with Alexa Fluro 594-Conjugated AffiniPure
goat anti-mouse and Alexa Fluro 488-Conjugated AffiniPure goat
anti-rabbit secondary antibodies (ZSGB-BIO, Beijing, China,
1:500) for 2 h at room temperature. Then cells were observed
under a confocal microscope (LSM710, ZEISS, Germany) at
high magnification and analyzed by using Image-Pro Plus 6.0.
(The specificity of the antibodies for the protein has not been
investigated.)
Measurement of Apoptosis
Apoptosis Assay Kit (Roche, Jinan, China) was used for TUNEL
staining for apotosis. All treated cells were observed under a
fluorescence microscope (Olympus, X51) and analyzed by using
Image-Pro Plus 6.0.
Western Blot Analysis
Protein samples were separated by SDS-PAGE and transferred
to NC membranes (Millipore), which were blocked with
5% milk and incubated overnight at 4◦C with the primary
antibody anti-ALDH2 (Abcam108306, Rabbit monoclonal to
ALDH2, Cambridge, MA, USA, 1:1000), anti-PINK1 (Cell
Signaling6946, Rabbit monoclonal to PINK1, Boston, MA, USA,
1:1000), anti-Parkin (Abcam15954, Rabbit polyclonal to Parkin,
Cambridge, MA, USA, 1:1000), anti-4HNE (Abcam46545, Rabbit
polyclonal to 4HNE, Cambridge, MA, USA, 1:1000), anti-Actin
(loading control, ZSGB-BIO, Beijing, China, 1:1000), and anti-
COX IV (mitochondrial loading control, Abcam33985, Mouse
monoclonal to COX IV, Cambridge, MA, USA, 1:1000), then with
goat anti-mouse and goat anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (ZSGB-BIO, Beijing, China,
1:10000) for 2 h at room temperature. After immunoblotting,
films were scanned and detected by the chemiluminescence
method. (The specificity of the antibodies for the protein has not
been investigated.)
Statistical Analysis
All data are expressed as mean ± SD value of at least
three independent experiments. One-way ANOVA was used for
comparisons. Post hoc Tukey’s test was performed for multiple-
range tests. P < 0.05 was considered statistically significant. Data
were analyzed with use of GraphPad Prism 5 (GraphPad Software
Inc., San Diego, CA, USA).
RESULTS
Myocardial Infarct Size and
Cardiomyocyte Apoptosis in I/R Rats
We first measured myocardial infarct size in SHAM, I/R,
I/R + Alda-1 and I/R + Daidzin groups after 30 min
coronary artery ligation and 2 h reperfusion in vivo. Compared
with I/R alone, I/R + Alda-1 reduced the infarct size and
I/R + Daidzin increased the size (Figures 1A,B). I/R-induced
cardiomyocyte apoptosis was alleviated with I/R + Alda-1.
Howerever, it had increasing trend, but no statistical significance
with I/R + Daidzin (Figures 1C,D). Therefore, ALDH2 plays a
key role in myocardial infarct size and cardiomyocyte apoptosis,
and ALDH2 activation confers cardioprotection.
ALDH2 Activity and Expression, 4HNE
Accumulation and Mitophagy in I/R Rats
In previous studies, PINK1/Parkin was a critical pathway
in controlling mitophagy involved in I/R-induced injury. To
explore the potential mechanism(s) under ALDH2-elicited
cardiac injury, the lipid peroxidation end product 4HNE, a
key ALDH2 substrate, and PINK1/Parkin were evaluated in
the rat myocardium. I/R damaged ALDH2 activity, which
was significantly alleviated and aggravated trend, respectively,
with Alda-1 and Daidzin treatment (Figure 2A) with no
change in ALDH2 expression (Figures 2B,C). To focus on the
effects of ALDH2 on mitophagy regulation, we found that I/R
increased PINK1 and Parkin levels. ALDH2 activation with
Alda-1 suppressed the I/R-elevated expression of PINK1 and
Parkin. However, ALDH2 inhibition with Daidzin could not
promoted their expression significantly (Figures 2D–F). I/R
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FIGURE 1 | Myocardial infarct size and cardiomyocytes apoptosis in I/R rats. (A) TTC staining for myocardial infarct size with representative tissue sectioning
for SHAM, I/R, I/R + Alda-1, the ALDH2 activator, and Daidzin, the inhibitor. (B) The infarct size was expressed as a percentage of area at risk (P < 0.0001, One-way
ANOVA). (C) TUNEL staining for myocardial tissue apoptosis. (D) Ratio of apoptosis (P < 0.0001, One-way ANOVA). n = 3/group. Representative TUNEL staining
images are shown (magnification, 200×). Scale bar: 50 µm. Data are mean ± SD from 3 independent experiments. ∗P < 0.05 vs. sham; #P < 0.05 vs. I/R.
treatment significantly enhanced 4HNE accumulation, which
was accentuated and mitigated by ALDH2 inhibition and
activation, respectively (Figures 2G,H). ALDH2 could play a
critical role in mitophagy regulation in myocardial I/R injury and
ALDH2 activation protect cardiomyocytes against I/R injury by
suppressing PINK1/Parkin–dependent mitophagy via reducing
4HNE accumulation.
ROS, MitoSOX, Mitochondrial Membrane
Potential and Apoptosis in H/R-Treated
H9C2 Cells
Studies have demonstrated that damaged and dysregulated
mitochondria generate redundant amounts of ROS, which
leads to myocardial damage (Steinberg, 2013). Mitochondria
are the major source of intracellular ROS (Starkov, 2008;
Kowaltowski et al., 2009). To investigate the relationship between
the ALDH2-mediated cardioprotection and oxidative stress,
we measured the levels of ROS, mitochondrial superoxide,
mitochondrial membrane potential and apoptosis in H/R-
treated H9C2 cells. Levels of ROS were higher with H/R
than with ALDH2 activation in cells. However, it had the
lower trend but no statistical significance with ALDH2
inhibition (Figures 3A,B). We also found that I/R increased
mitochondrial superoxide levels. ALDH2 activation with Alda-
1 suppressed the I/R-elevated mitochondrial superoxide levels
but ALDH2 inhibition with Daidzin promoted the levels
(Figures 3C,D). As well, ALDH2 activation significantly
alleviated the decreased mitochondrial membrane potential.
(Figure 3E). In line with the effects on myocardial I/R
injury, ALDH2 activation reduced H/R-induced apoptosis
but ALDH2 inhibition could not promoted it significantly
(Figures 3F,G). Above all, these findings supported a critical
role of ALDH2 in H/R-induced injury. ALDH2 activation
ameliorated the degree of mitochondrial membrane potential
damage and apoptosis by suppressing oxidative stress following
H/R challenge.
ALDH2 Activity, Expression, Cell Viability
and 4HNE Accumulation in H/R-Treated
H9C2 Cells
Consistant with previous results, H/R significantly decreased
ALDH2 activity, which was rescued by ALDH2 activation
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FIGURE 2 | ALDH2 activity and expression, 4HNE accumulation and mitophagy in I/R rats. (A) ALDH2 enzymatic activity (P < 0.0001, One-way ANOVA).
(B) Representative gel blots of expression of ALDH2 and Actin (loading control). Quantification analysis of (C) ALDH2 expression using specific antibodies
(P = 0.2671, One-way ANOVA). (D) Representative gel blots of expression of PINK1, Parkin and COX IV (mitochondrial loading control). Quantification analysis of
(E) PINK1 expression and (F) Parkin expression (P < 0.0001, P = 0.0012, One-way ANOVA). (G) Representative gel blots of expression of 4HNE. Quantification
analysis of (H) 4HNE expression (P < 0.0001, One-way ANOVA). n = 3/group. Data are mean ± SD from 3 independent experiments. ∗P < 0.05 vs. sham;
#P < 0.05 vs. I/R.
in H/R-treated H9C2 cells (Figure 4A) with no change in
ALDH2 expression (Figures 4C,D). Ratio of cell viability
was lower with H/R than with ALDH2 activation in cells
(Figure 4B). Considering the key role of 4HNE in ischaemic
cardiac injury, we examined the effect of ALDH2 on H/R-
induced 4HNE protein adduct formation. 4HNE protein
adduct formation was significantly increased in response
to H/R. Although ALDH2 inhibition significantly promoted
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FIGURE 3 | Continued
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FIGURE 3 | Continued
Reactive oxygen species, MitoSOX, mitochondrial membrane potential and apoptosis in H/R-treated H9C2 cells. (A) DCFH-DA for ROS formation.
Representative images are shown (magnification, 200×). Scale bar: 50 µm. (B) Quantification of fluorescence intensity of ROS (P < 0.0001, One-way ANOVA).
(C) MitoSOX for mitochondrial superoxide formation. Representative images are shown (magnification, 200×). Scale bar: 50µm. (D) Quantification of fluorescence
intensity of mitochondrial superoxide (P < 0.0001, One-way ANOVA). (E) Quantification of JC-1 intensity for mitochondrial membrane potential (P < 0.0001,
One-way ANOVA). (F) Ratio of apoptotic cells to total cells (P < 0.0001, One-way ANOVA). (G) TUNEL staining for H9C2 cell apoptosis. Representative images are
shown (magnification, 100×). Scale bar: 100 µm. Representative fluorescence images and quantitative analysis of 3 independent experiments. Data are mean ± SD
from 3 independent experiments. ∗P < 0.05 vs. CON; #P < 0.05 vs. H/R.
FIGURE 4 | ALDH2 activity and expression, cell viability and 4HNE accumulation in H/R-treated H9C2 cells. (A) ALDH2 enzymatic activity (P < 0.0001,
One-way ANOVA). (B) Cell viability (P < 0.0001, One-way ANOVA). (C) Representative gel blots of protein expression of ALDH2 and Actin (loading control).
(D) Quantification analysis of ALDH2 expression (P = 0.5003, One-way ANOVA). (E) Representative gel blots of expression of 4HNE. (F) Quantification analysis of
4HNE expression (P = 0.0002, One-way ANOVA). Data are mean ± SD from 3 independent experiments. ∗P < 0.05 vs. sham; #P < 0.05 vs. H/R.
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H/R-increased 4HNE protein adduct content, Alda-1 further
alleviated the increase (Figures 4E,F). Thus, ALDH2 activation
protected cardiomyocytes against I/R injury by reducing 4HNE
accumulation.
Mitophagy in H/R-Treated H9C2 Cells
We then determined the role of PINK1/Parkin in mitophagy
induction. H/R increased the co-localization of PINK1 or Parkin
with mitochondria, which suggests the activation of mitophagy
with H/R; Alda-1 reduced the increased co-localization of PINK1
or Parkin with mitochondria, which suggests suppression
of mitophagy activation after H/R (Figures 5A–D). As
expected, Alda-l reduced this expression induced by H/R.
However, Daidzin induced PINK1 and Parkin expression
but no significantly (Figures 5E–G). Therefore, ALDH2 may
protect cardiomyocytes against H/R injury by suppressing the
PINK1/Parkin pathway.
Effect of CCCP on ALDH2-Mediated
Cardioprotection in H/R-Treated H9C2
Cells
We used CCCP, an uncoupling protein, to induce mitiophagy
in H9C2 cells after H/R. Alda-1 significantly alleviated
ROS formation (Figures 6A,B), mitochondrial superoxide
(Figures 6C,D), decreased mitochondrial membrane potential
(Figure 6E), 4HNE accumulation (Figures 7E,F) and apoptosis
(Figures 6F,G). CCCP accentuated the inhibition of ALDH2
activity (Figure 7A), cell viability (Figure 7B) after H/R and
Alda-1 alleviated the CCCP-induced inhibition with no change
in ALDH2 expession (Figures 7C,D). Furthermore, CCCP
significantly promoted the increased co-localization of PINK1 or
Parkin with mitochondria (Figures 8A–D) and the expression of
PINK1/Parkin after H/R (Figures 8E–G) and Alda-1 alleviated
the increase. These data indicate that inhibition of mitophagy
may be involved in the cardioprotective effect of ALDH2 in H/R
injury.
DISCUSSION
The mitochondrial enzyme ALDH2 has been shown to
rescue I/R-induced myocardial injury (Ma et al., 2011). Our
present study provided compelling evidence that ALDH2
has protective effects in I/R or H/R-induced myocardial
injury by suppressing mitotophagy. The agonist of ALDH2,
Alda-1, may offer protection by alleviating I/R or H/R-
induced apoptosis via downregulating PINK1/Parkin-dependent
mitophagy by eliminating 4HNE accumulation or ROS and
MitoSOX formation; the inhibitior of ALDH2, Daidzin, was
associated with increased mitophagy activity. Overall, our
findings show the pivotal protective role of ALDH2 in myocardial
I/R injury by regulating mitophagy.
Many studies have demonstrated that ALDH2 overexpression
or activation alleviates myocardial injury induced by I/R (Ma
et al., 2011) diabetes, doxorubicin, acetaldehyde, and alcohol
(Doser et al., 2009; Ma et al., 2010; Wang et al., 2011; Zhang
et al., 2012). Nonetheless, the precise mechanism of the protective
effect of ALDH2 on myocardial I/R-induced injury in hearts
is unclear. In our study, we found that ALDH2 activation can
counteract injury by downregulating mitophagy via eliminating
4HNE accumulation or ROS and MitoSOX formation at both the
cardiac and H9C2 cell levels. We also showed the accentuated
trend that I/R- or H/R-induced myocardial injury under ALDH2
inhibition. Taken together, our results suggest that ALDH2 plays
a pivotal positive role in mediating cardiac protection against
ischemic injury.
Mitochondria, as the source of most energy production
and endogenous ROS production, play a key role in the
functioning and survival of cells (Yan et al., 2013). In
general, ROS damage all biomolecules leading to cell death
if in overabundance. Mitochondria are the major source of
intracellular ROS (Starkov, 2008; Kowaltowski et al., 2009).
Some studies demonstrated that leaky type 2 ryanodine receptor
(RyR2) cause mitochondrial Ca2+ overload, dysmorphology,
malfunction and dysfunction in HF (Santulli et al., 2015).
They also induce autophagy under pathological conditions
of starvation or in myocardial injury after I/R. Moreover,
I/R plays a key role in facilitating ROS-dependent lipid
peroxidation and production of 4HNE, a highly active carbonyl
lipid peroxidation end product (Petersen and Doorn, 2004).
4HNE has cardiac toxicity and impairs ATP production from
mitochondria and myocardial contractile function (Aberle
et al., 2004). It is one of the most important mediators for
lipid peroxidation-derived aldehyde-induced autophagy (Hill
et al., 2008). ALDH2 overexpression or activation conferred
cardioprotection via detoxification of 4HNE in myocardial
injury induced by I/R, doxorubicin, acetaldehyde, alcohol
(Doser et al., 2009; Ma et al., 2011; Zhang et al., 2012;
Sun et al., 2014). Overexpression or activation of ALDH2
conferred neuroprotection via clearance of 4HNE, whereas
ALDH2 knockdown mitigated the neuroprotective property of
protein kinase C in the pathogenesis of stroke (Guo et al.,
2013). Some studies reported that adduct formation on ALDH
itself results in decreased ALDH2 activity and a further rise
in 4HNE-induced cell toxicity (Traverso et al., 2002; Aberle
et al., 2004). Increased 4HNE adducts on ALDH2 protein in
the hearts of mice with symptoms of metabolic syndrome/type-
2 DM which may be the reason for the reduced ALDH2 activity
(Mali et al., 2014). Alterations of RyR2 and mitochondrial ROS
generation form a vicious cycle in the development of AF (Xie
et al., 2015). Consistent with previous reports, we observed that
H/R induced mitochondrial membrane potential depolarization,
ALDH2 activity reduction, ROS production, MitoSOX formation
and 4HNE accumulation, which were associated with increased
apoptosis in H9C2 cells. Restoration of ALDH2 activity and
elimination of ROS and mitochondrial superoxide are therefore
critically important.
Mitophagy is an important regulatory mechanism involving
selective elimination of dysfunctional mitochondria before
activation of cell death in several degenerative diseases
(Kubli and Gustafsson, 2012). The PINK1/Parkin pathway
is important in regulating mitophagy (Springer and Kahle,
2011). Many studies have shown that the antioxidant
superoxide dismutase 2 can squelch mitochondrial targeted
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FIGURE 5 | Mitophagy in H/R-treated H9C2 cells. (A) Representative immunostaining of co-localization of PINK1 and COX IV. (B) Co-localization ratio of PINK1
and COX IV. (P < 0.0001, One-way ANOVA). (C) Representative immunostaining of co-localization of Parkin and COX IV. (D) Co-localization ratio of PINK1 and COX
IV (P < 0.0001, One-way ANOVA). (E) Representative gel blots of expression of PINK1, Parkin and COX IV (mitochondrial loading control). Quantification analysis of
(F) PINK1 expression, (G) Parkin expression (P < 0.0001, P = 0.003, One-way ANOVA). Representative images are shown (magnification, 630×). Scale bar: 20 µm.
Representative immunostaining of 3 independent experiments. Data are mean ± SD from 3 independent experiments. ∗P < 0.05 vs. CON; #P < 0.05 vs. H/R.
photosensitizer-mitochondrial Killer Red (mtKR)–induced
PINK1/Parkin-dependent mitophagy, CCCP-induced ROS
production increases the Parkin/Pink1-mediated mitophagy in
neurons (Wang et al., 2012), which suggests that ROS induced
mitochondrial damage may be an important upstream activator
of mitophagy. Data from our study show upregulated ROS
production, MitoSOX formation, 4HNE level and PINK1/Parkin
pathway in I/R-induced myocardial injury. In cultured H9C2
cells, H/R induced significant mitophagy, which was associated
with activation of PINK1/Parkin. We also provide direct
evidence that ALDH2 activation with the agonist Alda-1
downregulated the PINK1/Parkin pathway and suppressed
subsequent apoptosis, ALDH2 inhibition with Daidzin had the
trend of upregulateing mitophagy and promoting apoptosis
in I/R-induced myocardial injury and HR-induced H9C2 cell
injury.
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FIGURE 6 | Continued
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FIGURE 6 | Continued
Effect of CCCP on ROS, MitoSOX, mitochondrial membrane potential and apoptosis in H/R-treated H9C2 cells. (A) DCFH-DA staining for ROS
formation. Representative images are shown (magnification, 200×). Scale bar: 50 µm. (B) Quantification of fluorescence intensity of ROS (P < 0.0001, One-way
ANOVA). (C) MitoSOX for mitochondrial superoxide formation. Representative images are shown (magnification, 200×). Scale bar: 50 µm. (D) Quantification of
fluorescence intensity of mitochondrial superoxide (P < 0.0001, One-way ANOVA). (E) Quantification of JC-1 intensity for mitochondrial membrane potential
(P < 0.0001, One-way ANOVA). (F) Ratio of apoptotic cells to total cells (P < 0.0001, One-way ANOVA). (G) TUNEL staining for H9C2 cell apoptosis. Representative
images are shown (magnification, 100×). Scale bar: 100 µm. Representative fluorescence of 3 independent experiments. Data are mean ± SD from 3 independent
experiments. ∗P < 0.05 vs. H/R; #P < 0.05 vs. H/R + CCCP.
FIGURE 7 | Effect of CCCP on ALDH2 activity and expression, cell viability and 4HNE accumulation in H/R-treated H9C2 cells. (A) ALDH2 enzymatic
activity (P < 0.0001, One-way ANOVA). (B) Cell viability (P < 0.0001, One-way ANOVA). (C) Representative gel blots of protein expression of ALDH2 and Actin
(loading control). (D) Quantification analysis of ALDH2 expression (P = 0.5138, One-way ANOVA). (E) Representative gel blots of expression of 4HNE.
(F) Quantification analysis of 4HNE expression (P = 0.001, One-way ANOVA). Data are mean ± SD from 3 independent experiments. ∗P < 0.05 vs. H/R; #P < 0.05
vs. H/R + CCCP.
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FIGURE 8 | Effect of CCCP on mitophagy in H/R-treated H9C2 cells. (A) Representative immunostaining of co-localization of PINK1 and COX IV.
(B) Co-localization ratio of PINK1 and COX IV (P < 0.0001, One-way ANOVA). (C) Representative immunostaining of co-localization of Parkin and COX IV.
(D) Co-localization ratio of PINK1 and COX IV (P < 0.0001, One-way ANOVA). (E) Representative gel blots of expression of PINK1, Parkin and COX IV (mitochondrial
loading control). Quantification analysis of (F) PINK1 expression, (G) Parkin expression (P < 0.0001, P = 0.002, One-way ANOVA). Representative images are
shown (magnification, 630×). Scale bar: 20 µm. Representative immunostaining of 3 independent experiments. Data are mean ± SD from 3 independent
experiments. ∗P < 0.05 vs. CON; #P < 0.05 vs. H/R + CCCP.
The current experiments involving a mitochondrial
depolarizing agent (CCCP) as a mitophagy pathway inducer
suggest that the loss of mitochondrial potential can activate
mitophagy (Wang et al., 2012). Our CCCP experiments
showed that mitophagy was upregulated with CCCP in H/R-
induced H9C2 cell injury and ALDH2 activation altered
this phenomenon. Thus ALDH2 activation, by suppressing
mitophagy, plays a critical role in protecting cardiomyocytes
under oxidative stress.
Interestingly, ALDH2 shows dual effects on autophagy
in I/R. ALDH2 overexpression moderates upregulated
autophagy via activated AMPK to inhibit mammalian target
of rapamycin (mTOR) in ischaemia and lessened autophagy
via Akt phosphorylation to activate mTOR when AMPK is
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no longer active in reperfusion phase (Ma et al., 2011). Our
data indicate that ALDH2 activation confers cardioprotection
through suppressed mitophagy after I/R or H/R. Further studies
are required to investigate whether ALDH2 is involved in the
paradoxical regulation of mitophagy and how this pathway is
regulated by ALDH2 in the ischaemia phase and the reperfusion
phase.
Many studies also clearly confirmed the important
cardioprotective role of autophagy and mitophagy in the
cardiovascular system, and enhancing mitophagy might
represent a promising future therapeutic target (Moyzis et al.,
2015). Autophagy is increased in the myocardium in response
to stress, and this is initially a protective response activated
by the cell (Hamacher-Brady et al., 2006). In I/R induced
myocardium injury, LC3-II to LC3-I ratio increased in ischemia,
decreased in I/R (Ma et al., 2011). Aged Calstabin2 deletion
mice impairs autophagy system which displayed increased p62
level, significantly lowered LC3-II to LC3-I ratio, and decreased
Beclin-1 level followed by cardiac aging (Yuan et al., 2014). In
cerebral-I/R, 3MA and Atg7 knockdown to inhibit autophagy
reinforced the brain and cell injury in the reperfusion phase,
whereas the mitophagy inhibitor Mdivi-1 in the reperfusion
phase and Park2 knockdown aggravated the ischemia-induced
neuronal injury (Zhang et al., 2013). PINK1-deficiency mice
increased heart failure more rapidly in response to pressure
overload than wild-type mice, and developed the susceptibility
of the heart to I/R injury ex vivo (Lee et al., 2011; Hoshino
et al., 2013). Parkin-deficient mice are more susceptible to
doxorubicin-mediated cardiotoxicity (Hoshino et al., 2013). It
also ccumulate dysfunctional mitochondria after a myocardial
infarction, which leads to increased mortality. In contrast,
augmented autophagy and excessive mitophagy is detrimental in
a model of pressure overload and reperfusion, which can promote
loss of myocytes (Matsui et al., 2007; Lu et al., 2009). However,
excessive activation of autophagy induced autophagic cell death
in myocardial I/R injury (Matsui et al., 2007; Qiao et al., 2013).
Our study indicated that activation of mitophagy was detrimental
during I/R and ALDH2 activation alleviated I/R-induced injury
in vivo and vitro by inhibiting mitophagy. Under severe oxidative
stress, the PINK1/Parkin pathway may be excessively activated in
response to I/R injury to induce myocardial cell death. ALDH2
activation inhibited over-activation of mitotophagy and increased
the survival of I/R cardiomyocytes.
More studies are required to fully understand how mitophagy
activity and mitochondrial morphology/function is regulated
under low and high oxidative stress whether myocardia can
be protected by controlling ALDH2 activity and expression.
And in our future studies, the antibodies specificity should be
investigated using corresponding knockout mice and transgenic
cells to consolidate our results.
CONCLUSION
In summary, we demenstrate that ALDH2 is cardioprotective
in a rat I/R model. ALDH2 inhibited excessive mitophagy
and increased the survival of I/R cardiomyocytes by reducing
4HNE and ROS levels. These findings may improve our
understanding of the molecular mechanisms responsible for
ALDH2 in protecting against myocardial I/R injury and provide
new insights for future therapeutic targets. Therapy aimed
at potentiating ALDH2 activitaty may be beneficial for in
myocardial I/R injury.
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